4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036796
President and CEO sold 239,437 shares at an average $0.76 ($181,573)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragan Paula President and CEO | 2023-11-01 | Sale 10b5-1 | −199,531 | $0.73 | $145,658 | 876,347 | D |
| Ragan Paula President and CEO | 2023-11-03 | Sale 10b5-1 | −39,906 | $0.90 | $35,915 | 836,441 | D |
| Open-market sales · 239,437 sh · avg $0.76 · $181,573 | |||||||
Loading xslF345X05/wk-form4_1699046800.xml…